Visipaque

GE Healthcare Inc.🇺🇸 United States

FDA Page

Effective Date: May 5, 2023
Approval ID: e9d87b8c-7695-4c0f-8e81-000dedb5f66d
Products: 2 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use VISIPAQUE safely and effectively. See full prescribing information for VISIPAQUE. VISIPAQUE (iodixanol) injection, for intra-arterial or intra-venous use Initial U.S. Approval: 1996

Quick Stats

Total Products2

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.